Emcure Pharmaceuticals SA (pty) Ltd Pharmaceutical Import Profile — South Africa (DGFT 2022–2026)

Name: Emcure Pharmaceuticals SA (pty) Ltd Pharmaceutical Import Records from India — 2 Products, $6.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Emcure Pharmaceuticals SA (pty) Ltd — Pharmaceutical Importer Profile (2026) | 2 Products, $6.7M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Emcure Pharmaceuticals SA (pty) Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Emcure Pharmaceuticals Limited	$627.4K	13	100.0%

Emcure Pharmaceuticals SA (pty) Ltd sources from 1 verified Indian supplier across 8 distinct formulations. The sourcing is highly concentrated — Emcure Pharmaceuticals Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Emcure Pharmaceuticals SA (pty) Ltd Import?

Formulation	Value	Ships
Pharma prod finished prod lavem 50 300 300 MG tablet 90s wtc dolutegravir lamivudine tenofovir disoproxil	$250.0K	5
Pharma prod finished prod cagol 600 50 300 MG tablet 28s abacavir dolutegravir lamivudine tablets 600 50 300MG	$100.0K	2
Pharmaceutical products finished product lavem 50 300 300 MG tablet 90s wtc dolutegravir lamivudine tenofovir	$50.0K	1
Pharmaceutical products finished goods lavem 50 300 300 MG tablet 90s wtc dolutegravir lamivudine tenofovir	$50.0K	1
Pharmaceuticals products finished product generic name lavem 50 300 300 mgtablet 90s wtc dolutegravir	$50.0K	1
Pharma prod finished prod cagol 600 50 300 MG tablet 28sabacavir dolutegravir lamivudine tablets 600 50 300MG	$50.0K	1
Pharmaceuticals products finished product generic name nitrofurantoin 100mgcapsule 5x10 nitrofurantoin	$46.9K	1
Pharmaceuticals products finished product generic name nitrofurantoin 50mgcapsule 5x10t nitrofurantoin

Emcure Pharmaceuticals SA (pty) Ltd imports 8 distinct pharmaceutical formulations. Showing top 8 by value. For full formulation-level data, contact TransData Nexus.

What Products Does Emcure Pharmaceuticals SA (pty) Ltd Import?

Top Products by Import Value

1Dolutegravir$4.1M 2Tenofovir$2.5M

Emcure Pharmaceuticals SA (pty) Ltd Therapeutic Categories — 1 Specializations

Emcure Pharmaceuticals SA (pty) Ltd imports across 1 therapeutic categories, with Antiviral & HIV Medications (100.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Antiviral & HIV Medications

2 products · 100.0% · $6.7M

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Dolutegravir	Antiviral & HIV Medications	$4.1M	82	0.1%	3
2	Tenofovir	Antiviral & HIV Medications	$2.5M	51	0.1%

Key Metrics

Total Import Value$6.7M

Products2

Shipments133

Categories1

CountrySouth Africa

#1 Rankings0

Indian Suppliers1

Formulations8

Top Categories

Antiviral & HIV Medications100.0%

Indian Suppliers

Last updated: March 28, 2026

Emcure Pharmaceuticals SA (pty) Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Emcure Pharmaceuticals SA (Pty) Ltd is a pharmaceutical importer and distributor based in Johannesburg, South Africa. As a subsidiary of Emcure Pharmaceuticals Limited, an Indian multinational pharmaceutical company headquartered in Pune, India, Emcure Pharmaceuticals SA (Pty) Ltd plays a pivotal role in the South African pharmaceutical supply chain. The parent company, Emcure Pharmaceuticals Limited, is renowned for its extensive portfolio, including tablets, capsules, injectables, and biotherapeutics across various therapeutic areas such as gynaecology, cardiology, oncology, and HIV antivirals.

In South Africa, Emcure Pharmaceuticals SA (Pty) Ltd serves as a key importer and distributor, facilitating the availability of Emcure's pharmaceutical products within the country. The company's operations are integral to ensuring that a diverse range of medications reaches healthcare providers and patients across South Africa, thereby contributing to the nation's healthcare infrastructure.

2Distribution Network

Emcure Pharmaceuticals SA (Pty) Ltd operates from its office located at Arizona House, First Floor, South Wing, 1 Madison Avenue Aspen Lakes, Ext 13, Gauteng 2190, Johannesburg, South Africa. While specific details regarding warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Johannesburg suggests a focus on efficient distribution within South Africa. Given Johannesburg's status as a major economic hub, Emcure Pharmaceuticals SA (Pty) Ltd is well-positioned to manage the importation and distribution of pharmaceutical products throughout the country.

Supplier Relationship Intelligence — Emcure Pharmaceuticals SA (pty) Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Emcure Pharmaceuticals SA (Pty) Ltd's sourcing strategy exhibits a high degree of concentration, with all its pharmaceutical imports originating from a single supplier: Emcure Pharmaceuticals Limited. This exclusive sourcing arrangement indicates a strategic partnership aimed at ensuring consistent product quality and supply chain reliability. The substantial import value of $6.7 million USD across 133 shipments underscores the significant volume of trade between the two entities. However, this single-source dependency also presents potential risks, such as supply chain disruptions due to unforeseen events affecting the sole supplier. The absence of alternative suppliers may limit Emcure Pharmaceuticals SA (Pty) Ltd's ability to mitigate such risks effectively.

2Supply Chain Resilience

The resilience of Emcure Pharmaceuticals SA (Pty) Ltd's supply chain is closely tied to the operational stability of Emcure Pharmaceuticals Limited. Given the exclusive sourcing relationship, any disruptions within the parent company's manufacturing or distribution processes could directly impact the subsidiary's ability to supply products in South Africa. The lack of backup suppliers and limited formulation diversity further heighten this vulnerability. Additionally, the reliance on a single shipping route for imports from India to South Africa exposes the supply chain to potential logistical challenges. Ensuring regulatory compliance of the key supplier is essential to maintain uninterrupted supply; however, the absence of alternative suppliers may complicate the process of obtaining necessary certifications and approvals.

3Strategic Implications

Emcure Pharmaceuticals SA (Pty) Ltd's sourcing pattern, characterized by exclusive reliance on Emcure Pharmaceuticals Limited, positions the company to benefit from streamlined operations and potentially favorable terms due to the close relationship. This strategic choice may enhance product availability and consistency in quality. However, the lack of supplier diversification could pose challenges in adapting to market changes or addressing supply chain disruptions. For Indian exporters seeking to become alternative suppliers, this presents an opportunity to offer complementary products or services that align with Emcure Pharmaceuticals SA (Pty) Ltd's existing portfolio, thereby reducing the perceived risk associated with introducing new suppliers.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into South Africa — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for South Africa

1Regulatory Authority & Framework

In South Africa, the South African Health Products Regulatory Authority (SAHPRA) is the primary body responsible for regulating the importation, registration, and distribution of medical products, including pharmaceuticals. SAHPRA operates under the Medicines and Related Substances Act 101 of 1965, as amended, which outlines the legal framework for the control of medicines and related substances in the country. This legislation mandates that all medicines imported into South Africa must be registered with SAHPRA, ensuring they meet the required standards of safety, efficacy, and quality. (sahpra.org.za)

2Import Licensing & GMP

To import pharmaceutical products into South Africa, companies must obtain an import license from SAHPRA. This license is contingent upon the supplier's adherence to Good Manufacturing Practices (GMP), which are internationally recognized standards ensuring the quality and safety of pharmaceutical products. SAHPRA requires that all pharmaceutical manufacturers and wholesalers comply with GMP guidelines, which are periodically updated to reflect best practices. Additionally, companies must be licensed and recorded as a manufacturing or wholesale pharmacy with the South African Pharmacy Council, and appoint a responsible pharmacist to oversee operations.

3Quality & Labeling

Pharmaceutical products imported into South Africa must undergo batch testing to verify their quality, safety, and efficacy. Stability studies are also required to ensure that products maintain their intended quality throughout their shelf life. Labeling requirements stipulate that all information be provided in English, and include details such as the product's name, dosage form, strength, batch number, manufacturing date, expiry date, storage conditions, and the name and address of the manufacturer. Serialization mandates may also apply to facilitate traceability and prevent counterfeit products from entering the market. (sahpra.org.za)

4Recent Regulatory Changes

Between 2024 and 2026, SAHPRA has implemented several policy changes affecting the importation of pharmaceutical products into South Africa. These changes include stricter enforcement of GMP compliance, updated labeling requirements to enhance patient safety, and the introduction of electronic systems for tracking and tracing imported medicines. Additionally, SAHPRA has streamlined the registration process for certain low-risk medicines to expedite market access. These regulatory updates aim to strengthen the integrity of the pharmaceutical supply chain and ensure that imported medicines meet the highest standards of quality and safety. (sahpra.org.za)

TransData Nexus Research · South Africa regulatory databasesMar 2026

Emcure Pharmaceuticals SA (pty) Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Emcure Pharmaceuticals SA (Pty) Ltd's focus on importing antiviral and HIV medications, particularly Dolutegravir and Tenofovir, aligns with the significant demand for HIV treatment options in South Africa. The country's high HIV prevalence necessitates a steady supply of effective antiretroviral therapies. By concentrating on these therapeutic areas, Emcure Pharmaceuticals SA (Pty) Ltd addresses a critical public health need, ensuring that patients have access to essential medications that are vital for managing and treating HIV infections.

2Sourcing Profile

Emcure Pharmaceuticals SA (Pty) Ltd's sourcing strategy is centered on obtaining finished pharmaceutical formulations from its parent company, Emcure Pharmaceuticals Limited. This approach leverages the parent company's extensive research and development capabilities, ensuring access to a diverse range of high-quality products. The focus on finished formulations, rather than active pharmaceutical ingredients (APIs) or bulk drugs, indicates a strategic decision to streamline operations and maintain consistent product quality. India's robust pharmaceutical manufacturing sector, characterized by adherence to international standards, complements Emcure Pharmaceuticals SA (Pty) Ltd's procurement strategy, facilitating the importation of reliable and effective medications.

3Market Positioning

Emcure Pharmaceuticals SA (Pty) Ltd serves a critical role in the South African pharmaceutical market by importing and distributing essential HIV medications. The company's product mix positions it to cater primarily to the needs of healthcare providers and patients requiring antiretroviral therapies. By focusing on these high-demand products, Emcure Pharmaceuticals SA (Pty) Ltd contributes significantly to the treatment and management of HIV in South Africa, thereby enhancing its standing within the healthcare sector.

TransData Nexus Research · DGFT trade data analysisMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Emcure Pharmaceuticals SA (pty) Ltd identified across shipments using consignee name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Emcure Pharmaceuticals SA (pty) Ltd's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 133 individual customs records matching Emcure Pharmaceuticals SA (pty) Ltd.
5.Supplier Verification: Emcure Pharmaceuticals SA (pty) Ltd sources from 1 verified Indian suppliers across 8 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2 Products Tracked

1 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Emcure Pharmaceuticals SA (pty) Ltd

Emcure Pharmaceuticals SA (pty) Ltd — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Emcure Pharmaceuticals SA (pty) Ltd?

What Formulations Does Emcure Pharmaceuticals SA (pty) Ltd Import?

What Products Does Emcure Pharmaceuticals SA (pty) Ltd Import?

Top Products by Import Value

Emcure Pharmaceuticals SA (pty) Ltd Therapeutic Categories — 1 Specializations

Import Portfolio — Top 2 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Emcure Pharmaceuticals SA (pty) Ltd — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Emcure Pharmaceuticals SA (pty) Ltd

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into South Africa — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Emcure Pharmaceuticals SA (pty) Ltd — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Emcure Pharmaceuticals SA (pty) Ltd

1Opportunity Assessment

2Requirements & Qualifications

Frequently Asked Questions — Emcure Pharmaceuticals SA (pty) Ltd

What products does Emcure Pharmaceuticals SA (pty) Ltd import from India?

Who supplies pharmaceuticals to Emcure Pharmaceuticals SA (pty) Ltd from India?

What is Emcure Pharmaceuticals SA (pty) Ltd's total pharmaceutical import value?

What therapeutic categories does Emcure Pharmaceuticals SA (pty) Ltd focus on?

Get Full Emcure Pharmaceuticals SA (pty) Ltd Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology